Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain
Data up to Jan 2025
Total Citations Per Year
Abstract
References (9)
A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
1941 • 3,174 citations
A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury
1990 • 1,819 citations
A method for measurement of analgesic activity on inflamed tissue.
1957 • 1,558 citations
The quantitative measurement of motor inco-ordination in naive mice using an accelerating rotarod
1968 • 539 citations
Broad-Spectrum, Non-Opioid Analgesic Activity by Selective Modulation of Neuronal Nicotinic Acetylcholine Receptors
1998 • 365 citations
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
1998 • 94 citations
Human α 7 nicotinic acetylcholine receptor responses to novel ligands
1995 • 87 citations
ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
1998 • 77 citations
Epibatidine: Pharmacological Properties of a Novel Nicotinic Acetylcholine Receptor Agonist and Analgesic Agent
1996 • 59 citations